Anti-tumor effects in combination with PARP inhibitor and DNMT inhibitor in ovarian cancer

被引：0
|
作者：
Lee, Jeong-Won [1 ]
Jeong, Soo Young [1 ]
Ryu, Ji Yoon [1 ]
Lee, Yoo-Young [1 ]
Esun, Paik [1 ]
机构：
[1] Samsung Med Ctr, Seoul, South Korea
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-377
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
377
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Rationale for combination PARP inhibitor and antiangiogenic treatment in advanced epithelial ovarian cancer: A review
    Secord, Angeles Alvarez
    O'Malley, David M.
    Sood, Anil K.
    Westin, Shannon N.
    Liu, Joyce F.
    GYNECOLOGIC ONCOLOGY, 2021, 162 (02) : 482 - 495
  • [32] PRECLINICAL STUDIES OF THE PARP INHIBITOR OLAPARIB IN COMBINATION WITH IMATINIB IN BRCA STRATIFIED OVARIAN CANCER
    Matheson, E.
    Salehan, M.
    Mukhopadhyay, A.
    Curtin, N. J.
    Drew, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 673 - 673
  • [33] Combining PARP inhibitor with TACC3 inhibition overcomes PARP inhibitor resistance in ovarian cancer
    Wu, Yu
    Wang, Qilong
    Deng, Chaolin
    Li, Mo
    Xiao, Yinan
    CANCER RESEARCH, 2024, 84 (06)
  • [34] Anti-tumor activity of the MEK inhibitor pimasertib in combination with the PI3K/mTOR inhibitor SAR245409 in low-grade serous ovarian cancer
    Sidhu, Sukhvinder S.
    Campana, Frank
    Egile, Coumaran
    Hsu, Karl
    Goodstal, Samantha
    Asatiani, Ekaterine
    Damstrup, Lars
    Lager, Joanne
    Ogden, Janet
    Vincent, Loic
    CLINICAL CANCER RESEARCH, 2013, 19
  • [35] Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer
    Ivy, S. Percy
    Liu, Joyce F.
    Lee, Jung-Min
    Matulonis, Ursula A.
    Kohn, Elise C.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (05) : 597 - 611
  • [36] Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
    Liu, Yuanyuan
    Song, Hong
    Song, Huanqing
    Feng, Xiaoxia
    Zhou, Chuan
    Huo, Zhifang
    AMB EXPRESS, 2019, 9 (1)
  • [37] Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
    Yuanyuan Liu
    Hong Song
    Huanqing Song
    Xiaoxia Feng
    Chuan Zhou
    Zhifang Huo
    AMB Express, 9
  • [38] Anti-tumor activity of a BRAF inhibitor and IFNα combination in BRAF mutant melanoma
    Sabbatino, Francesco
    Wang, Yangyang
    Scognamiglio, Giosue
    Favoino, Elvira
    Feldman, Steven A.
    Villani, Vincenzo
    Flaherty, Keith T.
    Nota, Sjoerd
    Giannarelli, Diana
    Simeone, Ester
    Anniciello, Anna M.
    Palmieri, Giuseppe
    Pepe, Stefano
    Botti, Gerardo
    Ascierto, Paolo A.
    Ferrone, Cristina R.
    Ferrone, Soldano
    CANCER RESEARCH, 2016, 76
  • [39] Impact of combination of PSK with TGF-beta inhibitor on anti-tumor immunity
    Hiroaki, Tanaka
    Yamazoe, Sadaaki
    Lwauchi, Takehiko
    Muguruma, Kazuya
    Kubo, Naoshi
    Kato, Yukihiro
    Morinnoto, Junya
    Kashiwagi, Shinichiro
    Fuyuhiro, Yuhiko
    Noda, Eiji
    Amano, Ryosuke
    Inoue, Toru
    Yamada, Nobuya
    Maeda, Kiyoshi
    Ohira, Masaichi
    Hirakawa, Kosei
    CANCER RESEARCH, 2010, 70
  • [40] The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells
    Lapinska, Karolina
    Housman, Genevieve
    Byler, Shannon
    Heerboth, Sarah
    Willbanks, Amber
    Oza, Anuja
    Sarkar, Sibaji
    ANTICANCER RESEARCH, 2016, 36 (11) : 5731 - 5742
12345